Richie Davis Quoted in 340B Report on How SCOTUS “Chevron” Decision Could Affect HRSA and 340B Regulation
Richie Davis, a Milwaukee-based partner in the Quarles & Brady Health & Life Sciences Practice Group, was quoted in a 340B Report article on how the Supreme Court’s “Chevron” decision could affect Health Resources and Services Administration (HRSA) and 340B regulation. Davis discussed the short-term impact of the decision and how the ruling is unlikely to significantly affect HRSA’s role in interpreting the 340B statute.
An excerpt:
“We haven’t seen the courts employing very much deference at all to the HRSA guidance and program interpretations over the last several years,” Davis said. “While this Supreme Court case represents the continued erosion of deference to agency actions, the immediate impact on 340B may be limited.”
…
“The 340B stature does provide a fair degree of detail as to what the ADR process should look like,” Davis said. “Though the Supreme Court ruling bolsters the chance of a potential challenge to the ADR rule, that might be an uphill battle given how well the 340B statute itself spells out the ADR process.”